Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Biomarkers Initially Identified in Whole Blood by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans

NCT01287923 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01287923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Biomarkers Initially Identified in Whole Blood by DNA Microarrays in Patients With Aggressive Lymphoma BMS_LyTrans
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
February 21, 2011
Completion date
September 1, 2017
Enrollment
326 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

dlbcl